«For 20 years we have been using rational bioengineering to modify the chemical structures
of clinically important natural products — using genetics to make a new molecule in a
process that parallels
medicinal chemistry — and that's what we were doing when we stumbled upon this,» said Professor Barrie Wilkinson from the John Innes Centre.